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EDITORIAL: INTRAVENOUS CO-INFUSION OF ADENOSINE AND NOREPINEPHRINE 
Robert A. Kloner, MD, PhD* 
Gregory Kay, MD** 
T he birth and increasing popularity of minimally invasive directed coronary artery bypass grafting 
(CABG) require new ways of better protecting the 
heart during such procedures ince standard car- 
dioplegic techniques are not possible with this ap- 
proach. There have been anecdotal reports of pro- 
tecting the myocardium to be revascularized by 
actually inducing brief coronary artery occlusions 
followed by reperfusion (ischemic preconditioning). 
An alternate technique would be to consider "chem- 
ical preconditioning" before interrupting blood sup- 
ply to protect the myocardium. 1 The concept of 
chemical preconditioning is one in which precondi- 
tioning-mimetic drugs, which are known to stimulate 
the biochemical pathways of preconditioning, but 
without inducing ischemia, are administered several 
minutes before coronary artery occlusion. The work 
of Liu and coworkers 2 has shown that adenosine 
receptor stimulation is an important mechanism of 
preconditioning. Both his group and our group have 
shown that the adenosine receptor agonist R(-)-N- 
(2-phenylisopropyl-adenosine. when administered 
before coronary occlusion, reduces the size of myo- 
cardial infarctions in rabbits. 3That adenosine may 
be important for the preconditioning phenomenon 
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in human beings was suggested by recent angio- 
plasty studies. Repetitive coronary occlusion and 
reperfusion i duced by angioplasty balloon inflation 
and deflation in patients is accompanied by a pro- 
gressive decrease in chest pain, ST segment deflec- 
tion, and lactate production. It has been suggested 
that this observation is a clinical counterpart to 
preconditioning. Adenosine blockers will prevent 
the beneficial effects of repetitive balloon inflation; 
conversely, adenosine administered before angio- 
plasty was shown to reduce initial ST segment 
change during the first balloon inflation. 4 A brief 
catecholamine stimulation with an al-adrenergic 
agent several minutes before coronary artery occlu- 
sion will also precondition the heart. 5The problem 
with administering adenosine or agents such as 
norepinephrine alone is their profound hemody- 
namic effects. Cohen and coworkers 6 are to be 
congratulated on their clever article in this issue of 
The Journal of Thoracic and Cardiovascular Surgery. 
They have shown that by giving adenosine and 
norepinephrine together, they counteract much of 
the adverse hemodynamic effects of either of these 
drugs alone and still obtain a substantial precondi- 
tioning effect. This observation has potentially im- 
portant clinical implications for the application of 
such therapy to ischemic syndromes. 
For chemical preconditioning towork, the dose of 
preconditioning-mimetic drugs must be adminis- 
tered temporally close to the long occlusion. Thus 
Cohen and associates 6 howed that norepinephrine 
plus adenosine significantly reduced experimental 
infarct size when given over 5 minutes starting 15 
minutes before the long coronary artery occlusion. 
However, the beneficial effect was less impressive if
the pharmacologi c agents were given 60 minutes 
before coronary artery occlusion; and the effect was 
totally lost when the agents were given 120 minutes 
before the coronary artery occlusion. A similar time 
course has been observed when preconditioning was 
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induced not by drugs but by brief periods of isch- 
emia created by coronary artery occlusion. 
If chemical preconditioning with adenosine plus 
norepinephrine b fore minimally invasive directed 
CAGB works, it could be extended as an adjunct o 
cardioplegia in more routine cases of CABG, or 
possibly these agents could be injected into the 
vasculature of excised donor hearts destined for 
transplantation] The premise of chemical precon- 
ditioning (and its advantage over mechanical pre- 
conditioning) is clear for the cardiac surgery patient: 
(1) Chemical preconditioning eed not interrupt the 
flow of the operation; (2) the entire myocardium is 
protected, not just the distribution of the single 
artery that is temporarily occluded; and (3) there is 
no trauma to the vessels. While current myocardial 
protection is excellent, it is not perfect. Stunning is 
still seen in the clinical setting and results in signif- 
icant morbidity. At a recent meeting, Mentzer and 
colleagues s uggested that adenosine may be useful 
as an adjunct to cardioplegia, and one possible 
mechanism for this is by stimulating the precondi- 
tioning pathway. Adenosine pretreatment before 
cardiopulmonary b pass was associated with better 
left ventricular function assessed by echocardiogra- 
phy and less use of inotropic agents in the postop- 
erative phase. Again, a major advantage ofchemical 
preconditioning is that the cardioprotective path- 
ways of ischemic preconditioning are stimulated 
without inducing ischemia or postischemic dysfunc- 
tion before the long occlusion. Whether chemical 
preconditioning with combinations of adenosine 
plus norepinephrine will work in patients undergo- 
ing minimally invasive directed CABG remains to be 
determined. Clearly large multicenter studies are 
needed to address the issue of whether chemical 
preconditioning can be used to better preserve 
ventricular myocardium during such procedures. 
Such a study should randomize patients to placebo 
versus adenosine plus norepinephrine about 15 min- 
utes before minimally invasive directed CABG. End 
points could include perioperative myocardial in- 
farction, peak creatine kinase MB isoenzyme, post- 
operative heart failure, regional wall motion deter- 
mined by serial echocardiograms, postoperative 
arrhythmias, length of stay in the hospital, and 
mortality. If these studies are positive, certainly it 
would be worth trying this combination of agents as 
an adjunct o routine CABG. 
In summary, Cohen and colleagues 6 have pub- 
lished an intriguing Study showing that by cOmbining 
two otherwise hemodynamically active agents, it is 
possible to minimize their hemodynamic effect while 
still causing a preconditioning-like effect. While the 
concept of ischemic preconditioning has been 
around for about 11 years, it is now time to try to 
apply this phenomenon to the therapy of patients 
with coronary artery disease. 
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